Strand, E.; Tangen, I.L.; Fasmer, K.E.; Jacob, H.; Halle, M.K.; Hoivik, E.A.; Delvoux, B.; Trovik, J.; Haldorsen, I.S.; Romano, A.;
et al. Blood Metabolites Associate with Prognosis in Endometrial Cancer. Metabolites 2019, 9, 302.
https://doi.org/10.3390/metabo9120302
AMA Style
Strand E, Tangen IL, Fasmer KE, Jacob H, Halle MK, Hoivik EA, Delvoux B, Trovik J, Haldorsen IS, Romano A,
et al. Blood Metabolites Associate with Prognosis in Endometrial Cancer. Metabolites. 2019; 9(12):302.
https://doi.org/10.3390/metabo9120302
Chicago/Turabian Style
Strand, Elin, Ingvild L. Tangen, Kristine E. Fasmer, Havjin Jacob, Mari K. Halle, Erling A. Hoivik, Bert Delvoux, Jone Trovik, Ingfrid S. Haldorsen, Andrea Romano,
and et al. 2019. "Blood Metabolites Associate with Prognosis in Endometrial Cancer" Metabolites 9, no. 12: 302.
https://doi.org/10.3390/metabo9120302
APA Style
Strand, E., Tangen, I. L., Fasmer, K. E., Jacob, H., Halle, M. K., Hoivik, E. A., Delvoux, B., Trovik, J., Haldorsen, I. S., Romano, A., & Krakstad, C.
(2019). Blood Metabolites Associate with Prognosis in Endometrial Cancer. Metabolites, 9(12), 302.
https://doi.org/10.3390/metabo9120302